Comments on: Exelixis- Going Where No Drug Has Gone Before http://www.orf-blog.com/exelixis-going-where-no-drug-has-gone-before/ Analyzing biotech stocks Wed, 22 May 2013 15:44:48 +0000 hourly 1 http://wordpress.org/?v=3.5.1 By: Ohad Hammer http://www.orf-blog.com/exelixis-going-where-no-drug-has-gone-before/#comment-2950 Ohad Hammer Fri, 25 Feb 2011 04:51:52 +0000 http://www.hammerstockblog.com/exelixis-going-where-no-drug-has-gone-before/#comment-2950 The impact of bone met resolution on OS is a cardinal issue. To me it sounds reasonable that it will have an effect, as bone is the primary site of metastasis in prosatate cancer, this is really the major tumor burden. But like everything else, you don’t know until you try and EXEL is going to evaluate it in trial #2.

Ohad

]]> By: provocateur http://www.orf-blog.com/exelixis-going-where-no-drug-has-gone-before/#comment-2949 provocateur Fri, 25 Feb 2011 04:42:43 +0000 http://www.hammerstockblog.com/exelixis-going-where-no-drug-has-gone-before/#comment-2949 As always, thanks for the article.Its a huge help in my investing decisions.Thanks for the help.

]]> By: provocateur http://www.orf-blog.com/exelixis-going-where-no-drug-has-gone-before/#comment-2948 provocateur Fri, 25 Feb 2011 04:40:05 +0000 http://www.hammerstockblog.com/exelixis-going-where-no-drug-has-gone-before/#comment-2948 This is getting interesting.I am not still sold if the bone scans mean anything.Does it create a PFS or OS endpoint.The FDA initial response is a huge question mark although I did play the trade and made some dough.

]]>